Nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy based on NADPH depletion

Hepatocellular carcinoma (HCC) is a malignant tumor leading cancer-associated high mortality worldwide. Unfortunately, the most commonly used drug therapeutics not only lack of target ability and efficiency, but also exhibit severe systemic toxicity to normal tissues. Thus, effective and targeted na...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Congyi, Liu, Zehui, Wang, Feng, Zhang, Bin, Zhang, Xirui, Guo, Peiwen, Li, Tianwei, Tai, Sheng, Zhang, Changmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809347/
https://www.ncbi.nlm.nih.gov/pubmed/36579634
http://dx.doi.org/10.1080/10717544.2022.2162160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809347/
https://www.ncbi.nlm.nih.gov/pubmed/36579634
http://dx.doi.org/10.1080/10717544.2022.2162160

Ejemplares similares